The deal – which could be worth up to $2.2 billion if PRX005 reaches the market – comes nearly a decade after BMS all-but exited the category after abandoning amyloid-targeting drug avagacestat.

Copyright © 2024 MarketWatch, Inc. All rights reserved.

From a technological perspective, it was Medarex that stole the show last year, although it is now part of Bristol-Myers Squibb (BMS), which splashed out $2.4 billion in cash for the Princeton ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

Well Cleaners Early Warning System (EWS) Copy link Watch on 0:00 / 3:01 ...

Notifications You must be signed in to change notification settings ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

Note - Repacks are compressed versions of games that exchange smaller downloads for longer installation times. Good if you have low bandwidth or data limits.

After earning $12m in its first four days, Pokémon TCG Pocket has now passed 30m downloads after a week. The smash-hit digital version of Pokémon's trading card game is off to a strong start ...

MA has received consulting and lecturing fees, travel grants and unconditional research support from Biogen, Janssen, Merck, Novartis, Roche, Sandoz, Sanofi and Celgene BMS. AS receives research ...

Keep your files, photos, and videos automatically backed up and available on all your devices.